HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Alberto-Culver

This article was originally published in The Rose Sheet

Executive Summary

Firm will launch new Nexxus hair care line comprising 25-30 SKUs next year, President and CEO Howard Bernick reports during Sept. 7 session at the Presidential Equity Group Back-to-School Consumer Conference in Boston. Collection will ship in January 2006, with plans to conduct advertising in March and April, exec adds. Bernick hinted at growing the Nexxus brand "substantially" in May, when the acquisition was announced (1"The Rose Sheet" May 16, 2005, p. 2). In addition, Alberto will support Sally Beauty Supply stores with national television advertising for the first time this holiday season, according to Bernick. Commenting on other Alberto brands, exec notes Tresemmé is the fourth-ranked hair care range at Wal-Mart and is expected to generate double-digit sales and volume growth in the U.S. in 2005...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013335

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel